2020 Medicare Advantage Prescription Drug Price Information |
Humana Gold Plus SNP-DE H4141-003 (HMO D-SNP) (H4141-003-0)
Benefit Details
![Email Prescription and/or Health Benefit details for Humana Gold Plus SNP-DE H4141-003 (HMO D-SNP). This function does not email the formulary drug list.](https://q1medicare.com/pics/ContentPics/email_medicare_plan_details.png) |
Monthly Premium: $22.00 Rx Deductible: $435 ICL: $4,020 Click on a letter below to view the Humana Gold Plus SNP-DE H4141-003 (HMO D-SNP) Formulary
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
0-9
|
This Plan Uses Lower Cost-Sharing for Preferred Pharmacies |
IBRANCE 100 MG TABLET ![Compare how all Medicare Part D PDP plans in GA cover IBRANCE 100 MG TABLET.](https://q1medicare.com/pics/ContentPics/compare_partd_plans_by_drug.png) |
Plan’s average negotiated retail drug price in in Oglethorpe, GA: CMS MA Region 8, includes: GA | $12,760.23* 30-Day Supply $38,262.42* 90-Day Supply
|
Formulary (Drug List) drug tier: | Tier 5
|
Does this plan offer any Gap coverage? | No |
Does this drug have Gap coverage? | No, this drug IS NOT covered in the gap, but all drugs receive the donut hole discount. |
Drug Usage Management Restrictions: | Prior Authorization and Quantity Limit:21/28Days
|
Formulary (Drug List) Tier Cost-Sharing Details |
|
30-Day Supply Cost-Sharing |
90-Day Supply Cost-Sharing |
Preferred Pharmacy |
Standard Pharmacy |
Mail- Order** |
Preferred Pharmacy |
Standard Pharmacy |
Mail- Order** |
Initial $435 Deductible Cost Sharing: |
| 100% | 100% | 100% |
n/a | n/a | n/a |
Initial Coverage Phase Cost-Sharing: |
| 25% | 25% | 25% |
n/a | n/a | n/a |
Coverage Gap Phase Cost-Sharing Incl. Donut Hole Discount (Generics 75%): |
| 25% | 25% | 25% |
n/a | n/a | n/a |
Coverage Gap Phase Cost-Sharing Incl. Donut Hole Discount (Brand 75%): |
| 25% | 25% | 25% |
n/a | n/a | n/a |
Catastrophic Coverage Phase Cost-Sharing for Generic & Preferred Multi-Source Drugs: |
| The greater of 5% or $3.60 |
The greater of 5% or $3.60 |
Catastrophic Coverage Phase Cost-Sharing for Other Drugs (Brand-Name or Non-Preferred Multi-Source Drugs): |
| The greater of 5% or $8.95 |
The greater of 5% or $8.95 |
Your Estimated Cost for Purchases During Each Coverage Phase |
|
30-Day Supply Cost-Sharing |
90-Day Supply Cost-Sharing |
Preferred Pharmacy |
Standard Pharmacy |
Mail- Order** |
Preferred Pharmacy |
Standard Pharmacy |
Mail- Order** |
Your Estimated Cost in Deductible Phase: |
| $2,824.84 | $2,824.84 | $2,824.84 |
n/a | n/a | n/a |
Your Estimated Cost Initial Coverage Phase: |
| $2,567.27 | $2,567.27 | $2,567.27 |
n/a | n/a | n/a |
Your Estimated Cost in Gap if Drug is Generic (75% discount): |
| $3,190.06 | $3,190.06 | $3,190.06 |
$6,993.12 | n/a | n/a |
Your Estimated Cost in Gap if Drug is Brand-Name (75% discount): |
| $1,974.85 | $1,974.85 | $1,974.85 |
$3,167.25 | n/a | n/a |
Your Estimated Cost in Catastrophic Coverage Phase (Generic): |
| $638.01 | $638.01 | $638.01 |
n/a | n/a | n/a |
Your Estimated Cost in Catastrophic Coverage (Brand-Name or Non-Preferred Multi-Source Drugs): |
| $638.01 | $638.01 | $638.01 |
n/a | n/a | n/a |
Tier Cost-Sharing Details and Your Costs with Explanations |
|
30-Day Supply Cost-Sharing |
90-Day Supply Cost-Sharing |
Preferred Pharmacy |
Standard Pharmacy |
Mail- Order** |
Preferred Pharmacy |
Standard Pharmacy |
Mail- Order** |
--- If you purchase during the Initial Deductible Phase --- |
Initial $435 Deductible Cost Sharing: |
| 100% | 100% | 100% |
n/a | n/a | n/a |
Your Estimated Cost in Deductible Phase: |
| $2,824.84 | $2,824.84 | $2,824.84 |
n/a | n/a | n/a |
Explanation for 30-Day Preferred Pharmacy purchase: |
|
For a purchase of this drug made during the initial deductible phase,
you cross over into other phases of your plan’s coverage (straddle claim).
So you pay 100% of the drug cost up to your deductible of $435
and the remaining amount ($12,760.23-$435) (price - deductible) falls
into your initial coverage phase (ICP).
For the ICP portion of your coverage, your cost-sharing would be an additional $896.25
or $3,585.00 x 25%
(overage up to your remaining coverage limit
($3,585.00) * cost-sharing). Since the amount of the retail drug price falling into the ICP
$12,325.23 is greater than the remaining
initial coverage limit $3585 ($4,020 - $435),
$8,740.23 rolls into the coverage gap phase. For the portion that falls into the coverage gap phase,
you would pay an additional
$1,320.72
or ($5,282.89 x 25% -- 70% of the discount counts toward TrOOP and the 5% paid by your plan does not count toward TrOOP assuming this is a brand-name drug). Since the portion of the costs that fell into the coverage gap
$8,740.23 x 95% exceeds the amount
of TrOOP left ($5,018.75),
$3,457.34 falls into the catastrophic coverage phase. For the portion that falls into the catastrophic coverage phase, you would pay an additional $172.87 or (5% of $3,457.34) since it is greater than the minimum catastrophic cost-share of $8.95. |
--- If you purchase during the Initial Coverage Phase --- |
Initial Coverage Phase Cost-Sharing: |
| 25% | 25% | 25% |
n/a | n/a | n/a |
Your Estimated Cost Initial Coverage Phase: |
| $2,567.27 | $2,567.27 | $2,567.27 |
n/a | n/a | n/a |
Explanation for 30-Day Preferred Pharmacy purchase: |
| The cost-sharing for purchases made during the initial coverage phase (ICP) would be $1,005.00 or ($4,020.00 x 25%). But since the retail drug price ($12,760.23) is greater than initial coverage limit ($4,020), the difference of $8,740.23 rolls into the coverage gap phase. For the portion that falls into the coverage gap phase,
you would pay an additional
$1,406.58
or ($5,626.32 x 25% -- 70% of the discount counts toward TrOOP and the 5% paid by your plan does not count toward TrOOP). The portion of the costs that fell into the coverage gap $5,626.32 exceeds the amount of TrOOP left ($5,345.00) so you only pay in the gap on the amount within the TrOOP. The excess over TrOOP, $3,113.91 falls into the catastrophic coverage phase. For the portion that falls into the catastrophic coverage phase,
you would pay an additional $155.70 or (5% of $3,113.91) since it is greater than the minimum catastrophic cost-share of $8.95. So, your total cost for this one purchase is $2,567.27 or $1,005.00 (ICP) + $1,406.58 (Gap) + $155.70 (Cat.Cov.). |
--- If you purchase during the Coverage Gap Phase (Donut Hole) --- |
Your Estimated Cost in Gap if Drug is Generic (75% discount): |
| $3,190.06 | $3,190.06 | $3,190.06 |
$6,993.12 | n/a | n/a |
Explanation for 30-Day Preferred Pharmacy purchase: |
| Your cost is the negotiated retail price of $12,760.23 x 25%. |
Your Estimated Cost in Gap if Drug is Brand-Name (75% discount): |
| $1,974.85 | $1,974.85 | $1,974.85 |
$3,167.25 | n/a | n/a |
|
Since 95% this drug’s negotiated
retail price ($12,760.23) is greater than
the TrOOP limit ($6,350), in the donut hole phase, you would pay
$1,671.05 (($6,350 / 95%) x 25% -- 70% of the discount counts toward TrOOP and the 5% paid by your plan does not count toward TrOOP)
plus $303.80 in the catastrophic phase, (which is 5% of the remaining
$6,076.02)
because $303.80 is greater than the minimum catastrophic cost-share of $8.95.
Although it rarely happens that you would be responsible for the entire
$6,350 for a purchase in the coverage gap, it can occur, for example
on an expensive generic drug with a $0 copay in the initial coverage phase. |
--- If you purchase during the Catastrophic Coverage Phase --- |
Catastrophic Coverage Phase Cost-Sharing for Generic & Preferred Multi-Source Drugs: |
| The greater of 5% or $3.60 |
The greater of 5% or $3.60 |
Your Estimated Cost in Catastrophic Coverage Phase (Generic): |
| $638.01 | $638.01 | $638.01 |
n/a | n/a | n/a |
Explanation for 30-Day Preferred Pharmacy purchase: |
| In the catastrophic coverage phase, you will pay the greater of 5% of the retail drug price or the minimum cost-share of $3.60. Calculating 5% of $12,760.23 = $638.01. Since $638.01 is more than $3.60, you would pay $638.01 for this drug at a preferred pharmacy, if it is a generic or preferred multi-source drug. |
Catastrophic Coverage Phase Cost-Sharing for Other Drugs (Brand-Name or Non-Preferred Multi-Source Drugs): |
| The greater of 5% or $8.95 |
The greater of 5% or $8.95 |
Your Estimated Cost in Catastrophic Coverage (Brand-Name or Non-Preferred Multi-Source Drugs): |
| $638.01 | $638.01 | $638.01 |
n/a | n/a | n/a |
Explanation for 30-Day Preferred Pharmacy purchase: |
| In the catastrophic coverage phase, you will pay the greater of 5% of the retail drug price or the minimum cost-share of $8.95. Calculating 5% of $12,760.23 = $638.01. Since $638.01 is more than $8.95, you would pay $638.01 for this drug at any pharmacy, if it is not a generic or preferred multi-source drug. |
Humana Gold Plus SNP-DE H4141-003 (HMO D-SNP) Average Negotiated Retail Drug Price History |
| 30-Day Supply | 90 Day Supply |
September, 2020: | $12,760.23 | $38,262.42 |
June, 2020: | $12,733.56 | $38,174.22 |
March, 2020: | n/a | n/a |
January, 2020: | n/a | n/a |
September, 2019: | | |
June, 2019: | | |
March, 2019: | | |
January, 2019: | | |
September, 2018: | | |
June, 2018: | | |
March, 2018: | | |
January, 2018: | | |
September, 2017: | | |
June, 2017: | | |
March, 2017: | | |
January, 2017: | | |
September, 2016: | | |
June, 2016: | | |
April, 2016: | | |
January, 2016: | | |
September, 2015: | | |
June, 2015: | | |
April, 2015: | | |
January, 2015: | | |
September, 2014: | | |
June, 2014: | | |
March, 2014: | | |
January, 2014: | | |
October, 2013: | | |
January, 2013: | | -- |
April, 2012: | | -- |
September, 2010: | | -- |
Notes:
*The Medicare drug plan’s average negotiated retail drug price is based on several
variables: the medication, the quantity of your prescription, the specific Medicare Part D
plan, and the pharmacies in the plan’s service area. In this case, the average of
the IBRANCE 100 MG TABLET prices that the Humana Gold Plus SNP-DE H4141-003 (HMO D-SNP) has negotiated with each of the retail pharmacies
in the plan’s service area (in Oglethorpe, GA: CMS MA Region 8, includes: GA).
In other words, when you use the Humana Gold Plus SNP-DE H4141-003 (HMO D-SNP) to purchase IBRANCE 100 MG TABLET, you may pay slightly more
or slightly less than the figures shown in the table above depending on the pharmacy where
you fill your prescription and the quantity of your prescription. The example average retail prices used above are based on a quantity of
21 for the 30-day supply and a quantity of 63 for the 90-day supply.
**The mail-order cost-sharing is the plan’s "preferred" mail-order cost-sharing.
|
Return to the Humana Gold Plus SNP-DE H4141-003 (HMO D-SNP) 2020 Formulary Browser by choosing a letter below:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
0-9
|